Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep778 | Thyroid | ECE2021

Thyroid nodule classified as Bethesda III: Our clinical experience and management strategy

Borja Sanz Martín , Roman Gimeno Sergio , Elena Pérez Galende , Sota Ochoa Patricia , Carlos Miguel Peteiro Miranda , Jose Jorge Ortez Toro , Urdaniz Borque Rosana

BackgroundThe prevalence of malignancy among Bethesda category III (atypia of undetermined significance) cytologies is variable in different studies.ObjectiveThe aim of this paper is to evaluate the risk of malignancy of thyroid nodules classified as Bethesda III in our hospital.MethodsWe have reviewed the medical records of 146 patients who underwent FNA with Bet...